Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
Price
Gainers & Losers
Weekly Gainers & Losers
Monthly Gainers & Losers
Super/Mega Movers
Out & Under Performers
Advances & Declines
Only Buyers / Sellers
Value Toppers
Arbitrage Opportunity
New Highs / Lows
52 Week Highs / Lows
LifeTime Highs / Lows
Exchange Turnover
Historical Return
Exchange Holidays
Volume
Volume Toppers
Block Deals
Bulk Deals
Highest & Lowest Delivery
Delivery Shockers
Unusual Volume Up/Down
Exchange Volume
Analysis
5 Day's Up/Down
Rising VDP
Rising VD Fall in P
Price Shockers
Indian Indices
Profit Report
Income Report
Industry Performance
Market Turnover Scripwise
Sector Watch
Special Tools
Above Moving Avarage
Below Moving Avarage
Bullish Reversal
Gap Up
Gap Down
Higher Opening
Lower Opening
Stocks < Previous Highs
Stocks < Previous Low
  News Analysis
Hot Stocks
Other Market
Corporate News
Market Pulse
Economy
Company Result
FII Position
Opening Bell
Midday Review
Closing Bell
Stock News
Global News
  Corporate Action
BSE / NSE Announcements
Book Closures
Board Meetings
Bonus Issues
Dividend Details
Right Issues
Corporate Results
Delisted Shares
Split of Face Value
Change of Name
Mergers
Demergers
  Other Market
FII Investments
DII Investments
World Indices
ADR Prices
Forex
  Company Profile
Company Details
Smart Quote
Share Prices
Company Background
Board Members
MF Holdings
Company News
Peer Companies News
Financials
Profit & Loss
Balance Sheet
Cash Flow
Financial Ratios
Share Holdings Pattern
Results
Quaterly
Quick Review
Company Reports
Director's Report
Derivatives
IPO
BSE Smart Quote
Glenmark Pharmaceuticals Ltd.
BSE Code 532296
ISIN Demat INE935A01035
Book Value (Rs) 650.55
NSE Code GLENMARK
Dividend Yield % 0.23
Market Cap(Rs Mn) 304777.32
TTM PE(x) 73.24
TTM EPS(Rs) 14.75
Face Value (Rs) 1  
 
Apr 26, 2024
Last Price  1080.05  
Prev.Close  1079.55  
Net Change  0.5  
52-Week High  1095.95  
Open  1081.30  
High  1088.35  
Low   1061.15
52-Week Low  516.65  
 
1 D | 1 M | 3 M | 1 Y
Stock Return Performance (in %) M Cap Sales
  Company Name 1W 1M 6M 1Y
Glenmark Pharma   5   13   44   107
Sun Pharma Inds.   -1   -6   36   55
Cipla   5   -4   23   55
Divi's Lab   10   19   18   25
Dr. Reddy's Lab   5   2   15   29
BSE HC   3   3   31   56
 Company Name 1W 1M 6M 1Y
Glenmark Pharma   5   13   44   107
Sun Pharma Inds.   -1   -6   36   55
Dr. Reddy's Lab   5   2   15   29
Cipla   5   -4   23   55
Aurobindo Pharma   4   7   32   84
BSE HC   3   3   31   56
Sensex   1   2   17   22
 
News
More
Key Maket Ratio
Latest EPS 14.75 MktCap/Sales 4.09
Latest CEPS 22   P/CEPS 50
Price / BV 1.66 Price / Sales 0.01
EV / EBIDTA 21.45 EV / Sales 4.54
Div Yield % 0.23    
Results Standalone Consolidated
TTM Latest 4 Quarters Quarter on Quarter
Particulars Prev.TTM
Net Sales  80672 
PBDIT 14167 
PAT 15518 
EPS 55 
Dec 2023Sep 2023Jun 2023Mar 2023
13651223342144419390
-1843443548502177
-20430242717-1375
-11110-5
Dec 2022  Var %
21615  -37 
4388  -142 
4305  -105 
15  -105 
TTM Latest 4 Quarters Quarter on Quarter
Particulars Prev.TTM
Net Sales  126355 
PBDIT 21368 
PAT 9531 
EPS 31 
Dec 2023Sep 2023Jun 2023Mar 2023
25067320743401633737
-2086462363126050
-4496-18031731-4031
-17-75-15
Dec 2022  Var %
34639  -28 
6202  -134 
2908  -255 
10  -272 
MF Holding Details
 
Competitors
 Peer CompaniesLTP%Chg
Divi's Lab 4025.35 4.81
Sanofi India 8278.1 1.76
Abbott India 25864.85 0.54
Astrazeneca Pharma I 5415.4 2.18
Glaxosmithkline Phar 2132.75 3.26
Disclaimer  |  Privacy Policy  |  Rules and Regulation  |  Terms Of Use     Copyright 2008-2009 IITGROUP
Designed | Developed & Content Powered By www.accord.com ACCORD FINTECH